Follow-The-Filings

Security · featured owners

TVTX

Travere Therapeutics Inc. COM Equity as of 2026 Q1 among managers we track

  • 2 Owners
  • Max 1.1%
  • $9M
  • 1 new 1 add 1 exit

Who owns this now

Largest portfolio weights among featured holders · max 1.1% (Palo Alto Investors) · not free-float ownership

  1. Palo Alto Investors add 1.1%
  2. Polen Capital Management new 0.02%

holders

sorted by % of portfolio · long equity only · exits show last held size · open a manager for their book

history
Palo Alto Investors 2026 Q1 1.1% Add +108.1% 230,453 $7M hist
Polen Capital Management 2026 Q2 stale 0.02% New 0.0% 34,315 $2M hist
Farallon Capital Management exited 2026 Q2 last 2026 Q1 0% Exit 0.00 pp 12,000 $357K hist

2 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $30.89M $233.18M $490.73M
Gross profit * $19.44M $225.43M $480.39M
Gross margin * 62.9% 96.7% 97.9%
Net income -$86.33M -$321.54M -$25.55M
Net margin * -279.5% -137.9% -5.2%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $616.78M $416.7M $437.56M
Total non-current assets * $172.14M $177.42M $167.63M
Total assets $788.91M $594.12M $605.19M
Total current liabilities $177.91M $200.75M $159.9M
Total non-current liabilities * $410.2M $334.3M $330.46M
Total equity $200.81M $59.08M $114.83M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$280.02M -$237.48M $37.78M
Cash from investing $55.78M $99.32M $27.89M
Cash from financing $218.75M $139.42M -$33.47M
Net change in cash -$3.51M $359,000 $34.5M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders